Lysodren Shortage Update: What Patients Need to Know in 2026

If you've been searching for information about a Lysodren shortage, you're not alone. Patients across the country have reported difficulty accessing this critical medication, prompting widespread confusion about whether Lysodren is actually in shortage. The answer is nuanced — and understanding it is key to getting your medication. Here's what you need to know in 2026.

Is Lysodren Currently in Shortage?

As of 2026, Lysodren is not listed as a shortage drug on the FDA Drug Shortages database. The FDA tracks shortages when drug manufacturers cannot meet demand or when supply disruptions affect availability. Lysodren's situation is different: it is not in shortage because of a manufacturing problem — it is simply very difficult to access due to how it is distributed.

Lysodren treats adrenocortical carcinoma (ACC), an extremely rare cancer affecting fewer than 300–500 new patients in the United States each year. Because the patient population is so small, Lysodren is distributed through a tightly controlled specialty pharmacy network — not at your neighborhood CVS or Walgreens. This structural limitation is what creates the "shortage-like" experience that many patients describe.

Why Patients Experience Access Difficulties Even Without an Official Shortage

The access challenges with Lysodren are real, even if they don't meet the technical definition of a drug shortage. Here's why patients run into trouble:

Specialty-only distribution: Lysodren is distributed exclusively through Direct Success Inc. and cannot be ordered through standard pharmaceutical wholesalers. Most retail pharmacies simply have no pathway to stock it.

Insurance prior authorization delays: Commercial health plans often require prior authorization before covering Lysodren. This process can take days to weeks and, if denied, requires an appeal — all while the patient is waiting for their cancer treatment.

Limited prescriber awareness: ACC is so rare that many community oncologists may have never prescribed Lysodren before. This can lead to delays while the care team learns the specialty pharmacy enrollment process.

Cost barriers: With no generic available and retail costs exceeding $3,800 for 100 tablets, patients without insurance or with poor coverage may face severe cost barriers even if the drug is technically available.

A Brief History of Lysodren Availability

Lysodren has been FDA-approved since 1970 — making it one of the oldest cancer drugs still in regular use. It was historically distributed by Bristol-Myers Squibb before being acquired and transferred to ESTEVE Pharmaceuticals. The transition between manufacturers has at times led to temporary distribution disruptions. Currently, ESTEVE manufactures Lysodren and manages the U.S. distribution through Direct Success Inc.

Because Lysodren is the only FDA-approved drug for ACC, even small disruptions in its supply chain can have a disproportionate impact on patients. There have been periods — particularly during company transitions — when patients reported longer-than-normal wait times for their prescriptions to be filled.

What Should I Do If I'm Having Trouble Getting Lysodren Right Now?

Take these steps immediately if you're experiencing access problems:

Call the Lysodren support line at 1-844-LYSODREN (1-844-597-6373). This is Direct Success Inc., the authorized distributor. They can help locate a dispensing pharmacy and check your insurance and copay eligibility.

Contact your oncologist immediately if you're at risk of running out. Do not wait for a refill to be denied before raising the alarm. Physicians can often expedite things through their institutional relationships.

Use medfinder to find pharmacies near you that carry specialty oncology medications. medfinder calls pharmacies on your behalf and texts you the results.

Ask about patient assistance programs if cost is a barrier. Commercial insurance patients typically pay no more than $80/month with the manufacturer's copay support. The PAN Foundation and Prescription Hope also offer assistance.

What Happens If I Can't Get Lysodren for a Period of Time?

Lysodren has a very long half-life (18 to 159 days), and the drug accumulates in adipose tissue. This means that plasma levels don't drop immediately after stopping — the drug continues to be released from fat stores over a long period. However, treatment gaps are still clinically significant, especially if you are in active disease treatment.

Your oncologist may use ketoconazole, metyrapone, or another steroidogenesis inhibitor to bridge hormone control while Lysodren access is restored. Never stop or modify your treatment plan without consulting your care team.

How to Stay Ahead of Access Problems

The best defense against Lysodren access problems is planning ahead. Request refills 2 to 3 weeks before you run out rather than at the last minute. If you've recently moved or changed insurance plans, contact the specialty pharmacy immediately to ensure your account and insurance information are up to date. And if you ever need help locating a pharmacy that can fill your prescription, medfinder is there to help.

See also: How to Find Lysodren In Stock Near You (Tools + Tips).